InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Rosa-Bjorkeson Dagmar. Insider active across 2 companies, notably Intercept Pharmaceuticals, INC.. In total, 7 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €46k. History available since 27 May 2021. The latest transaction was disclosed on 27 September 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Rosa-Bjorkeson Dagmar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
2,503 shares@ US$20.68100.0% of flowCommon StockSEC:0001127602-24-024682:0
5,986 shares0Common StockSEC:0001127602-24-018836:0
14,766 shares@ US$19.00100.0% of flowCommon StockSEC:0001104659-23-117104:0
5,007 shares0Common StockSEC:0001127602-23-019285:0
8,111 shares0Common StockSEC:0001104659-23-064841:0
7,737 shares0Common StockSEC:0001104659-22-065901:0
10,543 shares0Common StockSEC:0001104659-21-075217:0
7 of 7 declarations
About Rosa-Bjorkeson Dagmar
ROSA-BJORKESON DAGMAR is a declarant and a director at Intercept Pharmaceuticals, INC. and Xencor Inc. There are 8 filings in total, and among the sampled recent filings the reported volumes are 0 EUR of buys and 46310 EUR of sells, between 2021-06-01 and 2024-10-01.
